Table 2.

Characteristics of the 11 patients with a confirmed diagnosis of SARS-CoV-2 infection.

Patient	COVID confirmed	IgG antinucleocapside	Anti-N index	IgG anti-Spike	Disease	Treatment	COVID-19 infection reported by interview	PCR	CT	Care support	Severity	Need of oxygen
Patient 1a	Serology + symptoms + PCR + CT	Positive	1.77	Positive	RA	MTX + HCQ + RTX	Headache, myalgia, diarrhea, arthralgia, dry cough, rhinorrhea, anosmia, agueusia	Positive	Typical	Ambulatory	Moderate	No
Patient 2a	Serology + symptoms + PCR + CT	Positive	2.78	Positive	RA	MTX + RTX	Fever, headache, odynophagia, cough, expectoration, dyspnea, chest pain, myalgia, diarrhea, anosmia, agueusia	Positive	Typical	Medicine department	Severe	Yes
Patient 3	Serology + symptoms	Positive	1.48	Positive	SpA	MTX + IFX	Cough, fever, myalgia	Suspicious	NA	Ambulatory	Low	No
Patient 4	Serology + symptoms	Positive	2.26	Positive	SpA	SSZ + IFX	Fever, cough, headache, anosmia, agueusia	NA	NA	Ambulatory	Low	No
Patient 5	Serology + symptoms	Positive	2.02	Positive	SpA	NSAID	Anosmia, agueusia, headache	NA	NA	Ambulatory	Low	No
Patient 6	Serology + symptoms	Positive	6.41	Positive	SpA	MTX + IFX	Odynophagia, cough, expectoration, rhinorrhea, arthralgia, myalgia	Negative	NA	Ambulatory	Low	No
Patient 7	Serology + symptoms	Positive	3.28	Positive	SpA	IFX	Anosmia, agueusia, chills	NA	NA	Ambulatory	Low	No
Patient 8	Serology + no symptoms	Positive	1.44	Positive	RA	MTX + IFX	Asymptomatic	NA	NA	Ambulatory	Low	No
Patient 9	Serology and anti S positive	Undetermined	0.58	Positive	RA	Corticosteroids	Asymptomatic	NA	NA	Ambulatory	Low	No
Patient 10	Symptoms + PCR + CT	Inconclusive	0.21	Negative	RA	ABA	Fever, asthenia, agueusia	Positive	Typical	Medecine department	Moderate	No
Patient 11	Symptoms + PCR + CT	Negative	0.01	Negative	RA	MTX + RTX	Diarrhea, cough, dyspnea	Positive	Typical	Medecine department	Moderate	Yes

NSAID: non-steroidal anti-inflammatory drugs; MTX: methotrexate; HCQ: hydroxychloroquin; RTX: rituximab; SLZ: sulfasalazine; IFX: infliximab.

^aPatients treated with Rituximab.